BioPharmSignal logoBioPharmSignal

Biotech News

Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence

Privia Health (PRVA)Privia HealthCompany update

ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2026 MAP (Measure, Apply, Perform) Award for High Performance in Revenue Cycle,

Related news

PRVAPrivia Health2026-08-18 13:00 EST

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

PRVAPrivia Health2026-08-06 10:00 EST

Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results

View all latest news

Privia Health

Physician Enablement Platform Privia Health supports independent physicians with technology and services that allow practices to remain physician-led while operating within scaled medical groups. Provider Networks The company builds primary-care-centered provider networks, risk-bearing entities and local medical groups with shared...

Recent company news

PRVAPrivia Health2026-08-18 13:00 EST

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

PRVAPrivia Health2026-08-06 10:00 EST

Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results

PRVAPrivia Health2026-07-07 13:00 EST

Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

PRVAPrivia Health2026-05-27 13:00 EST

Privia Health Enters New Jersey

PRVAPrivia Health2026-05-07 10:00 EST

Privia Health Reports First Quarter 2026 Financial Results

Stock data

Close
21.12 USD
Market cap
2.62B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States